Tourmaline Bio Inc (NAS:TRML)
$ 14.44 -0.06 (-0.41%) Market Cap: 370.34 Mil Enterprise Value: 169.34 Mil PE Ratio: 0 PB Ratio: 1.43 GF Score: 24/100